ArticlePloS one2010

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.

Maureen J Donlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.